Human Apolipoprotein H Antibody (IgG) ELISA Kit (Sandwich ELISA)
Catalog Number: LS-F67372-1
1 plate / $591.00
Reactivity: Human
Detection Method Colorimetric
Format: 96-Well Strip Plate
Western blot of recombinant CXCL5. This image was taken for the unconjugated form of this product. Other forms have not been tested.
CXCL5 Antibody (aa45-118)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunocytochemistry, Western Blot |
| Reactivity: | Mouse |
| Format: | Liquid |
$308.00each
Catalog Number: LS-C293780-100
Catalog Number: LS-C293780
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- CXCL5 antibody LS-C293780 is an unconjugated rabbit polyclonal antibody to mouse CXCL5 (aa45-118). Validated for WB. Cited in 1 publication.
- Application
- ICC, WB
- Reactivity
- Ms
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- C-X-C motif chemokine 5 | CXCL5 | ENA-78(1-78) | GCP-2 | ENA78 | SCYB5 | ENA-78 | Small inducible cytokine B5 | Small-inducible cytokine B5 | LIX | AMCF-II
- Recommended Dilution: WB
- 1:100 - 1:400
- UniProt Number
- P42830
- NCBI GenBank
- NM_002994 | NP_002985.1
- SwissProt
- P42830
Target
- Target
- Mouse CXCL5
- Antigen Species
- Mouse
- Epitope
- The antibody is a rabbit polyclonal antibody raised against ENA78.
- Gene Name
- CXCL5
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- Recombinant ENA78 (Val45-Ala118) expressed in E. coli.
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- 0.01 M PBS, pH 7.4, 0.05% ProClin™ 300, 50% Glycerol
- Concentration
- 1 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
- Recommended Storage Buffer
- 0.01 M PBS
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. Balamayoora Theivanthiran, Kathy S Evans, Nicholas C DeVito, Michael Plebanek, Michael Sturdivant, Luke P Wachsmuth, April Ks Salama, Yubin Kang, David Hsu, Justin M Balko, Douglas B Johnson, Mark Starr, Andrew B Nixon, Alisha Holtzhausen, Brent A Hanks. The Journal of clinical investigation. 2020 May;130:2570-2586. PubMed: 32017708 PMC: PMC7190922
